Calls Purchased on GTx, Inc.

Shares of GTx, Inc.

are higher on the session by 10.67%, currently trading at $5.81. The stock has been moving largely higher over the past three months and is currently trading above the 200-day moving average. Options traders are buying calls on the name today. A short while ago the July 2011 $7.00 call was purchased 500 times, on the offer, on open interest of 44 contracts. Overall call volume is now running at 5.89x the daily average with 92% of all calls traded being purchases on the offer. GTx, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that targets hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical conditions.